Table 1.
Cells/Tissue | In Vitro Model of Senescence | Evaluations | Main Results | Ref. |
---|---|---|---|---|
NP cells from healthy SD rats (6–8 wks old) |
Group 1: cells; Group 2: cells + TNFα (20 ng/mL) and IL1β (20 ng/mL) |
Cell proliferation (CCK8 assay); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); TE activity (ELISA); ROS content (ROS assay); AGG, COLL II, p53, p16, MMP3, MMP13, ADAMTS4 gene expression (RT-PCR); AGG, COLL II proteins (ICC); p16, p53 proteins (WB) |
Group 2: ↑ ROS content, SA-β-Gal, G0/G1 phase, p16, p53, MMP3, MMP13 and ADAMTS4 expression; ↓ cell viability, TE activity, S phase, AGG, and COLL II proteins than group 1 |
Li et al., 2019 [19] |
NP cells and discs from healthy SD rats (6–8 wks old) |
Group 1: cells; Group 2: cells + TNFα (10 ng/mL); Group 3: discs; Group 4: discs + TNFα (200 ng/mL) |
Cell proliferation (CCK8 assay); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); TE activity, ROS content (ELISA); p16, p53, AGG, COLL II gene expression (RT-PCR); AGG, COLL II, ERα, ERβ proteins (ICC); p16, p53, AGG, COLL II, NF-κB p65, p-NF-κB p65, ERα, ERβ proteins (WB); GAG, HYP content; AGG, COLL II proteins (IHC) |
Groups 2, 4: ↓ cell viability, TE activity, AGG and COLL II proteins; ↑ SA-β-Gal, ROS, and p53 and p16 proteins than groups 1, 3 |
Li et al., 2017 [20] |
NP cells from healthy SD rats (6–8 wks old) |
Group 1: cells; Group 2: cells + TNFα (10, 20, 40 ng/mL); Group 3: cells + TNFα (10 ng/mL) + recovery in normal culture conditions; Group 4: cells + TNFα (10 ng/mL) without recovery |
Cell proliferation (CCK8 assay); Cell viability (LIVE/DEAD); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); TE activity (ELISA); p53, p16, AGG, COLL II, AKT gene expression (RT-PCR); GAG content (DMMB assay); AGG, COLL II proteins (ICC) |
Groups 2, 4: ↓ cell proliferation, TE activity, AGG and COLL II proteins; ↑ p53, p16, and AKT expression than group 1 in a dose-dependent manner. Group 3: similar results than group 4 |
Li et al., 2017 [21] |
NP cells from healthy SD rats (4 wks old); BMSCs from healthy SD rats (4–5 days old) |
Group 1: cells + blank calcium alginate gel balls; Group 2: cells treated with TNFα (20 ng/mL) + blank calcium alginate gel balls; Group 3: cells treated with TNFα (20 ng/mL) + calcium alginate gel balls with BMSCs; Group 4: cells treated with TNFα (20 ng/mL) + calcium alginate gel balls with NP cells |
Cell viability (CCK8 assay); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); p16, p21, p53 gene expression (RT-PCR); COLL II, MMP9, ZMPSTE24, RelA proteins (IF) |
Groups 2, 4: ↑ SA-β-Gal than groups 1, 3. Groups 2, 4: ↑ SA-β-Gal, MMP9 protein, p16, p21, and p53 expression; ↓ ZMPSTE24 protein than group 3 |
Li et al., 2019 [22] |
Discs of healthy pigs (3–4 mo old) |
Group 1: discs; Group 2: discs + intermittent compression (0.1 MP at 1.0 Hz for 2 hrs) + perfusion-culture; Group 3: discs + intermittent compression (1.3 MP at 1.0 Hz for 2 hrs) + perfusion-culture |
Cell senescence (SA-β-Gal staining); PG distribution (Alcian Blue staining); AGG, COLL II, TIMP1, TIMP3, ADAMTS4, MMP3, p16, p53 gene expression (RT-PCR); p38, p-p38, p16, p53 proteins (WB); AGG, COLL II, PCNA proteins (IHC); GAG, HYP content (Biochemical measurement) |
Group 3: ↑ SA-β-Gal, p38, p-p38, p16, p21, p53, ADAMTS4, and MMP3 proteins; ↓ AGG, COLL II, GAG, HYP, and PCNA proteins, TIMP3 expression than groups 1, 2 | Pang et al., 2017 [23] |
NP cells from healthy SD rats (7–8 wks old), suspended in collagen solution and seeded into DBM |
Group 1: cells; Group 2: cells + 20% dynamic compression (1.0 Hz for 6 hrs/day) |
Cell proliferation (CCK8 assay); Cell senescence (SA-β-Gal staining); Cell cycle (Flow cytometry); TE activity, ROS content (ELISA); p16, p53 gene expression (RT-PCR); p16, p53, NF-κB p65, p-NF-κB p65 proteins (WB) |
Group 2: ↓ cell proliferation; ↑ SA-β-Gal, p53, p16, and NF-κB proteins, ROS content than group 1 |
Jiang et al., 2018 [24] |
Discs from healthy pigs (12–13 mo old) |
Group 1: discs; Group 2: discs + static compression (0.4 MP at 1.0 Hz for 4 hrs/day); Group 3: discs + dynamic compression (0.4 MP at 1.0 Hz for 4 hrs/day) |
Cells senescence (SA-β-Gal staining); TE activity (ELISA); AGG, COLL II, p16, p53 gene expression (RT-PCR); COLL II, AGG proteins (IHC); p53, p16 proteins (WB); GAG, HYP content (Biochemical measurement) |
Group 2: ↑ SA-β-Gal, p16 and p53 proteins; ↓ TE activity, AGG, COLL II, GAG, and HYP proteins than groups 1, 3. Group 3: ↓ SA-β-Gal, p16 and p53 proteins; ↑ TE activity, AGG, COLL II, GAG, and HYP proteins than groups 1, 2 |
Shi et al., 2018 [25] |
AF cells from healthy SD rats (3 mo old) |
Group 1: cells; Group 2: cells + 5% elongation (1 Hz for 8 hrs/day); Group 3: cells + 20% elongation (1 Hz for 8 hrs/day) |
Cell proliferation (CCK8 assay); Cell cycle (Flow cytometry); TE activity (ELISA); AGG, COLL II, BCL1, LC3, p53, p16 gene expression (RT-PCR); p16, p53, AGG, COLL II, BCL1, LC3 proteins (WB) |
Group 1: similar results than group 2; Group 3: ↓ cell proliferation, TE activity, S phase, AGG, COLL II, BCL1, and LC3 proteins; ↑ G0/G1 phase, p16, and p53 proteins than groups 1, 2 |
Zhao et al., 2019 [26] |
NP cells from healthy SD rats (8 wks old) |
Group 1: cells; Group 2: cells + H2O2 (0.05–0.15 mM) |
Cell morphology (H/E, toluidine blue staining); Cell proliferation (CCK8 assay); Cell senescence (SA-β-Gal staining); Nuclear morphology (Hoechst staining); ROS level; Cell cycle, apoptosis (Flow cytometry); TNFα, IL1β, IL6, IL8 gene expression (RT-PCR); p53, p21, p16 proteins (WB) |
Group 2: ↑ SA-β-Gal, p53, p21, and p16 proteins, TNFα, IL1β, IL6, and IL8 expression; ↓cell viability and proliferation than group 1 |
He et al., 2019 [27] |
NP cells from healthy subjects (nr) |
Group 1: cells; Group 2: cells + H2O2 (0–2 mM) |
ROS kinetics (DCFH-DA assay); Cell viability (MTT assay); Cell proliferation (DNA synthesis assay); Cell cycle (Flow cytometry); Cell senescence (SA-β-gal staining); Telomere length; p16, p21 Catalase, SOD, COX2, ADAMTS4, ADAMTS5, MMP1, MMP2, MMP9, MMP13, TIMP1, TIMP2, TIMP3, ACAN, Biglycan, Decorin, Versican gene expression (RT-PCR); PARP, p-p38, p38, p-SAPK/JNK, SAPK/JNK, p-AKT, AKT, p-Chk2, p-p53, p-ERK1/2, panERK, p21, p-ATM, p53, p16, pRb proteins (WB); p-H2A.X (IF) |
Group 2: ↑ ROS; ↓ cell proliferation than group 1. Group 2 at 0.5 mM: ↑ p-38, H2A.X, and p53 proteins, SA-β-gal, ROS, and ECM-degrading enzymes; ↓ ECM structural components |
Dimozi et al., 2015 [28] |
NP and AF cells of healthy Wistar rats (2 mo old); NP and AF cells from healthy Wistar rats (2 and 22 mo old); NP and AF cells from pz with disc herniation (nr); NP and AF cells from healthy subjects (nr) |
Group 1: cells from pz; Group 2: cells from pz + γ-ray (60Co gamma, 2 Gy/min); Group 3: cells from young rats + γ-ray (60Co gamma, 2 Gy/min); Group 4: cells from old rats + γ-ray (60Co gamma, 2 Gy/min); Group 5: cells from healthy individuals + γ-ray (60Co gamma, 2 Gy/min) |
Cell proliferation (BrdU incorporation assay); Cell senescence (SA-β-gal staining); GL13 protein (ICC); p16, GL13 proteins (IHC) |
Group 2: ↓ cell proliferation; ↑ SA-β-gal, GL13 proteins than group 1. Group 4: ↑ SA-β-gal, GL13 protein than group 3. Group 2: ↑ p16, GL13 proteins than group 5 |
Veroutis et al., 2021 [29] |
NP cells from healthy bovine (nr) |
Group 1: cells; Group 2: cells + 10% FBS, 4.5 mg/mL glucose, 300 mOsm/kg H2O, 20% O2 + γ-ray (60Co gamma, 2.5 Gy/min); Group 3: cells + serum-free, 0.9 mg/mL glucose, 400 mOsm/kg H2O, 2% O2 + γ-ray (60Co gamma, 2.5 Gy/min) |
Cell proliferation (BrdU incorporation); Cell senescence (SA-β-Gal staining); p16, p21, ICAM1, MMP1, MMP2, MMP3, ADAMTS4, ADAMTS5, AGG, COLL II gene expression (RT-PCR) |
Group 2: ↓ cell proliferation, ↑ SA-β-Gal than group 1. Groups 2, 3: ↑ p16, p21, ICAM1, MMP1, MMP2, MMP3, AGG, and MMP1 expressions; ↓ COLL II expression than group 1 |
Kouroumalis et al., 2019 [30] |
Purchased human Chons | Group 1: cells + monoenergetic C-ions (75–95 MeV/mm); Group 2: cells + X-ray (225 kV, 13 mA); Group 3: cells in collagen scaffold + monoenergetic C-ions (75–95 MeV/mm); Group 4: cells in collagen scaffold + X-ray (225 kV, 13 mA) |
Cell proliferation (Flow cytometry); Cell toxicity (Bioluminescent cytotoxicity assay); Cell senescence (SA-β-gal staining); Cell apoptosis (Flow cytometry); COX2, p21, Caspase-3 proteins (WB) |
Group 1: ↓ cell viability than group 2. Groups 1, 3: ↑ SA-β-gal than groups 2, 4. Groups 3, 4: ↑ p21; ↓ COX2 than groups 1, 2 |
Hamdi et al., 2015 [31] |
Chons from healthy horses (4–7 yrs old); Chons from cadavers (38–73 yrs old) |
Group 1: cells; Group 2: cells + γ-ray (10 Gy); Group 3: cells + TGFβ1 and bFGF; Group 4: cells + γ-ray (10 Gy) + TGFβ1 and bFGF |
Cell senescence (SA-β-gal staining); MMP13, IL6, IGFBP3, CCL2 gene expression (RT-PCR); p16, γH2AX proteins (IF) |
Group 2: ↑ SA-β-gal, p16, γH2AX than group 1; Group 4: ↑ SA-β-gal, γH2AX, and p16 proteins, IGFBP3 and CCL2 gene expressions than groups 2, 3 |
Copp et al., 2021 [32] |
BMSCs from healthy SD rats (3 wks old); Chons from healthy SD rats (3 wks old) |
Group 1: BMSCs; Group 2: Chons; Group 3: BMSCs + Chons; Group 4: Chons + γ-ray (1.080 Gy/min for 10 min); Group 5: BMCs + Chons + γ-ray (1.080 Gy/min for 10 min) |
Cell proliferation (EdU incorporation assay); Cell senescence (SA-β-Gal staining); Bax, Bcl-2, CDKN2A, CDKN1A, IL6, MMP1, MMP13, Sox9, IL1β, Coll II, Nanog, Oct-4 gene expression (RT-PCR); Caspase-3 protein (IHC); COLL II, AGG proteins (WB) |
Group 4: ↑ SA-β-Gal, IL6 and MMP13 expression, Caspase-3 protein; ↓ proliferation, Bax/Bcl2, IL1β and COLL II expression than group 2. Group 5: ↓ proliferation, COLL II gene expression and protein; ↑ Caspase-3 protein, Bax/Bcl2, Oct4 and Nanog expression, SA-β-Gal, AGG protein than groups 1, 3 |
Cao et al., 2019 [33] |
Chons from healthy subjects (28–59 yrs old) |
Group 1: cells; Group 2: cells cultured for 24 hrs + IL1β (10 ng/mL) |
Cell proliferation (CCK8 assay); Cell apoptosis (Flow cytometry); Cell senescence (SA-β-gal staining); COLL II, ADAMTS5, MMP13 gene expression (RT-PCR); GRP78 protein (WB) |
Group 2: ↓ COLL II expression; ↑ ADAMTS5 and MMP13 gene expressions, GRP78 protein than group 1 |
Liu et al., 2017 [34] |
Chons from NZW rabbits (1 mo old) and rats (2 wks old) |
Group 1: rabbit cells + serum-starved overnight conditions + DKK1 (100 ng/mL) + IL1β (10 ng/mL); Group 2: rabbit cells + serum-starved overnight conditions + LiCl (20 mM) + IL1β (10 ng/mL); Group 3: rabbit cells; Group 4: rat cells + serum-starved overnight + Wnt-1 (10 ng/mL); Group 5: rat cells; Group 6: rat cells + serum-starved overnight + Wnt-1 (10 ng/mL) + IL1β (10 ng/mL); Group 7: rat cells + serum-starved overnight + Wnt-1 (10 ng/mL) + PBS |
Cell senescence (SA-β-gal staining); MMP13, p53, 18s rRNA, MMP3 gene expression (RT-PCR); β-catenin, MMP13, MMP3, p16, p53, acetylated p53, SIRT-1 proteins (WB) |
Group 2: ↑ β-catenin, MMP13, and acetylated p53, SIRT-1 proteins than group 1. Group 4: ↑ cell senescence, p53, and p16 proteins than group 5. Group 6: ↑ MMP3 and MMP13 proteins than group 7 |
Li et al., 2020 [35] |
Chons from cartilage of preserved (P-C) and severely damaged (D-C) areas of OA pz (nr) |
Group 1: Chons micromasses from P-C; Group 2: Chons micromasses from D-C |
Cell proliferation (Flow cytometry); Cell senescence (SA-β-gal staining); Telomere length (TAT assay); p16INK4a, p21, p53, COLL II, SOX9, AGG, Ats4, Ats5, MMP12, MMP13, COLL I, COLL III, VCAN, IL6, IL8, p16, SA-β-gal gene expression (RT-PCR); p16INK4a, MMP13 proteins (IHC); COLL II, p16INK4a proteins (IF); SOX9, MMP13, p21, p53, p16 proteins (WB); GAG content (Safranin O/Fast green staining) |
Group 2: ↓ cartilage matrix deposition, telomere length, COLL II, SOX9, and AGG expression; ↑ MMP13, p16, p21, and p53 proteins and expressions than group 1 |
Wang et al., 2022 [36] |
Purchased C2C12 (10th–12th in vitro passages) |
Group 1: myotubes; Group 2: myotubes + 10% of serum of fasted young donors; Group 3: myotubes + 10% of serum of old donors |
Desmin protein (ICC); IgG2a monoclonal antipuromycin, p-mTOR, mTOR, p-Akt, Akt, p-p70S6K1, p70S6K1, p-4EBP-1, 4EBP1, p-RPS-6, RPS-6, p-eEF2, eEF2, LC3A/B, Caspase-3, MuRF-1, F-box (WB) |
Group 2: ↑ myotube diameter and NFI, Akt, p70S6K1, and eEF2 proteins than groups 1, 3. Group 3: ↓ Myotube diameter than group 1 |
Allen et al., 2021 [37] |
Purchased C2C12 cells | Group 1: cells + 5% plasma from young subjects; Group 2: cells + 5% plasma from old subjects |
Cell proliferation (cell counter); Scratch assay; Cell diameter |
Group 1: ↓ scratch size; ↑ cell diameter, proliferation than group 2 | Kalampouka et al., 2018 [2] |
Purchased human myoblasts | Group 1: cells at 1st passage + simulated microgravity (1 × 10−3 G; µG); Group 2: cells at 1st passage + normal gravity (1 G); Group 3: cells at 5th passage + normal gravity (1 G) |
Cell proliferation assay; Cell senescence (SA-β-Gal activity); Desmin, Myf5 proteins (ICC); Cytoskeleton areas and nuclei analysis; Differentiation into myotubes (IF for MHC) |
Groups 2, 3: ↑ MHC and desmin proteins, myotubes diameter, cell proliferation; ↓ Myf5 protein than group 1. Groups 1, 3: ↑ SA-β-Gal than group 2 |
Takahashi et al., 2021 [38] |
BMSCs from OA pz |
Group 1: cells at 10th passage; Group 2: cells at 4th passage |
Tri-lineage differentiation; CFU assay; Cell proliferation (Flow cytometry, MTT); Cell senescence (SA-β-gal staining); Telomere length (TAT assay); p16, MMP13 proteins (IHC); p16, p21, p53, COLL II, SOX9, AGG, Ats4, Ats5, MMP12, MMP13, COLL I, COLL III, VCAN, IL6, IL8, SA-β-gal gene expression (RT-PCR); COLL II, p16 proteins (IF); SOX9, MMP13, p21, p53, p16INK4a proteins (WB) |
Group 1: ↓ proliferation, differentiation potential, telomere length, COLL II, SOX9, and AGG expressions and proteins; ↑ p16, SA-β-gal, MMP13, p21, and p53 expressions and proteins than group 2 | Wang et al., 2022 [36] |
NPMSCs from pz (37–52 yrs old) |
Group 1: cells; Group 2: cells + TNFα (10 ng/mL) |
Cell viability (Calcein-AM); Cell senescence (SA-β-Gal staining); Cell proliferation (CCK8 assay); p16, p21, p53, IL6, MMP13, ADAMTS5, brachyury, FOXF1, Pax1, CA12, HIF1α, COLL Iα1, COLL IIα1, SOX9, AGG, LPL, PPAR2, ALP, Runx2 gene expression (RT-PCR); COLL II, CA12 proteins (IF, WB); GAG content (DMMB assay) |
Group 2: ↑ senescent cell morphology, SA-β-Gal, p16, p21, p53, IL6, MMP13, and ADAMTS5 expressions than group 1 |
Li et al., 2018 [39] |
Abbreviations: Ref = references; NP = nucleus pulposus; SD = Sprague–Dawley; wks = weeks; TNFα = Tumor necrosis factor α; IL = interleukin; CCK8 = cell counting kit-8 reagents; Sa-β-Gal = Senescence-associated β-galactosidase; TE = telomerase; ELISA = enzyme-linked immunosorbent assay; ROS = reactive oxygen species; AGG = aggrecan; COLL = collagen; MMP = matrix metalloproteinase; ADAMTS = a disintegrin and metalloproteinase with thrombospondin motifs; RT-PCR = real time PCR; ICC = Immunocytochemistry; WB = Western blotting; GAG = glycosaminoglycan; HYP = hydroxyproline; IHC = Immunohistochemistry; ER = estrogen receptor; DMMB = dimethylmethylene blue; BMSCs = bone marrow mesenchymal stem cells; ZMPSTE24 = zinc metallopeptidase STE24; IF = immunofluorescence; mo = months; hrs = hours; PG = proteoglycan; TIMP = tissue inhibitor of metalloproteinase; PCNA = proliferating cell nuclear antigen; NF-κB = nuclear factor kappa-light-chain-enhancer of activated B cells; AF = Annulus Fibrosus; H2O2 = hydrogen peroxide; BrdU = 5-bromo-2′-deoxyuridine; Chons = chondrocytes; COX-2 = cyclooxygenase-2; yrs = years; bFGF = basic fibroblastic growth factor; TGFβ = transforming growth factor beta; IGFBP3 = insulin-like growth factor binding protein 3; CCL2 = C-C motif chemokine ligand 2/monocyte chemoattractant protein 1; GRP78 = 78-KDa glucose-regulated protein; NZW = New Zealand white; NPMSCs = nucleus pulposus mesenchymal stem cells; DBM = decalcified bone matrix; DCFH-DA = Dichloro-dihydro-fluorescein diacetate; ECM = extracellular matrix; pz = patients; ICAM1 = intercellular adhesion molecule 1; Oct-4 = octamer-binding transcription factor 4; CDKN = cyclin dependent kinase inhibitor; LiCl = Lithium chloride; PBS = Phosphate buffered saline; SIRT-1 = Sirtuin-1; DKK1 = Dickkopf-1; OA = osteoarthritis; TAT = telomere analysis technology; EEF2 = Eukaryotic Translation Elongation Factor 2; NFI = Nuclear Factor I; MuRF1 = Muscle RING-finger protein-1; RPS6 = Ribosomal Protein S6; EIF4EBP1 = Eukaryotic Translation Initiation Factor 4E Binding Protein 1; µG = microgravity; G = gravity; MYF5 = Myogenic Factor 5; MHC = Myosin heavy chain; CFU = colony-forming unit; ALP = alkaline phosphatase; RUNX2 = Runt-related transcription factor 2; PPAR = peroxisome proliferator-activated receptors; LPL = Lipoprotein lipase; HIF = Hypoxia-inducible factor; H/E= Hematoxylin/Eosin; CA12 = Carbonic anhydrase 12; nr = not reported; ↑ = increase; ↓ = decrease.